Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase

Haematologica

Volumn 99, Issue 3, 2014, Pages 570-578

  Ferru, Emanuela ^a   Pantaleo, Antonella ^b   Carta, Franco ^c   Mannu, Franca ^c   Khadjavi, Amina ^a   Gallo, Valentina ^a   Ronzoni, Luisa ^d   Graziadei, Giovanna ^d   Cappellini, Maria Domenica ^d   Turrini, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Nurex Srl   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN; CARBONATE DEHYDRATASE; CATALASE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN; P72SYK KINASE; PEROXIREDOXIN 2; TRANSFERASE; UNCLASSIFIED DRUG; HEMICHROME; HEMOPROTEIN; PROTEIN KINASE INHIBITOR; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ARTICLE; CHEMICAL REACTION; CONFOCAL MICROSCOPY; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE MICROPARTICLE; PHAGOCYTOSIS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; REDOX ACTIVATION; SPLENECTOMY; THALASSEMIA; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION;

CELL-DERIVED MICROPARTICLES; ENZYME ACTIVATION; ERYTHROCYTES; HEMEPROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; THALASSEMIA;

EID: 84895736561     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.084533     Document Type: Article

References (49)

1. Taher AT, Musallam KM, Cappellini MD, Weatherall DJ. Optimal management of beta thalassaemia intermedia. Br J Haematol. 2011;152(5):512-23.
2. Camaschella C, Kattamis AC, Petroni D, Roetto A, Sivera P, Sbaiz L, et al. Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia. Am J Hematol. 1997;55(2):83-8.
3. Sampietro M, Cazzola M, Cappellini MD, Fiorelli G. The triplicated alpha-gene locus and heterozygous beta thalassaemia: a case of thalassaemia intermedia. Br J Haematol. 1983;55(4):709-10.
4. Harteveld CL, Refaldi C, Cassinerio E, Cappellini MD, Giordano PC. Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis. 2008;40(3):312-6.
5. Sollaino MC, Paglietti ME, Perseu L, Giagu N, Loi D, Galanello R. Association of alpha globin gene quadruplication and heterozygous beta thalassemia in patients with thalassemia intermedia. Haematologica. 2009; 94(10):1445-8.
6. Rachmilewitz EA, Thorell B. Hemichromes in single inclusion bodies in red cells of beta thalassemia. Blood. 1972; 39(6):794-800.
7. Mannu F, Arese P, Cappellini MD, Fiorelli G, Cappadoro M, Giribaldi G, et al. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes. Blood. 1995;86(5):2014-20.
8. Shinar E, Rachmilewitz EA. Oxidative denaturation of red blood cells in thalassemia. Semin Hematol. 1990;27(1):70-82.
9. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010;8(10):2152-8.
10. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000; 111(2):467-73.
11. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol. 2008;142(1):126-35.
12. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev. 2006;20(1):1-26.
13. Hahalis G, Kalogeropoulos A, Terzis G, Tselepis AD, Kourakli A, Mylona P, et al. Premature atherosclerosis in non-transfusion-dependent beta-thalassemia intermedia. Cardiology. 2011;118(3):159-63.
14. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM, et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation. 2004;109 (13):1653-9.
15. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004;286(5): H1910-5.
16. Sadallah S, Eken C, Martin PJ, Schifferli JA. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol. 2011;186(11):6543-52.
17. Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, et al. Multiple members of the TNF superfamily contribute to IFNgamma-mediated inhibition of erythropoiesis. J Immunol. 2005;175(3):1464-72.
18. Banyatsuppasin W, Butthep P, Atichartakarn V, Thakkinstian A, Archararit N, Pattanapanyasat K, et al. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/beta-thalassemia patients. Am J Hematol. 2011;86 (1):89-92.
19. Ferru E, Giger K, Pantaleo A, Campanella E, Grey J, Ritchie K, et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood. 2011, 2;117(22):5998-6006.
20. Pantaleo A, Ferru E, Giribaldi G, Mannu F, Carta F, Matte A, et al. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem J. 2009;418(2):359-67.
21. Repka T, Shalev O, Reddy R, Yuan J, Abrahamov A, Rachmilewitz EA, et al. Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes. Blood. 1993;82(10):3204-10.
22. Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, Siritanaratkul N, et al. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom. 2004;57(1):23-31.
23. Winterbourn CC. Free-radical production and oxidative reactions of hemoglobin. Environ Health Perspect. 1985;64:321-30.
24. Pantaleo A, Ferru E, Carta F, Mannu F, Simula LF, Khadjavi A, et al. Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells. PloS one. 2011;6(1):e15847.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-5.
26. Pantaleo A, Ferru E, Carta F, Mannu F, Giribaldi G, Vono R, et al. Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth. Proteomics. 2010;10(19):3469-79.
27. Campanella ME, Chu H, Wandersee NJ, Peters LL, Mohandas N, Gilligan DM, et al. Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood. 2008;112(9):3900-6.
28. Cappellini MD, Tavazzi D, Duca L, Graziadei G, Mannu F, Turrini F, et al. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Br J Haematol. 1999;104(3):504-12.
29. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood. 2004;104(10):3364-71.
30. Salzer U, Zhu R, Luten M, Isobe H, Pastushenko V, Perkmann T, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion. 2008;48(3):451-62.
31. Landolt-Marticorena C, Charuk JH, Reithmeier RA. Two glycoprotein populations of band 3 dimers are present in human erythrocytes. Mol Membr Biol. 1998;15 (3):153-8.
32. Montoro-Garcia S, Shantsila E, Marin F, Blann A, Lip GY. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol. 2011;106(6):911-23.
33. Chaichompoo P, Kumya P, Khowawisetsut L, Chiangjong W, Chaiyarit S, Pongsakul N, et al. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients. J Proteomics. 2012;76 Spec No.: 239-50.
34. Pantaleo A, Giribaldi G, Mannu F, Arese P, Turrini F. Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions. Autoimmun Rev. 2008;7(6):457-62.
35. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006;37(1):12-20.
36. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96(4): 488-91.
37. Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G. Coagulation and splenectomy: an overview. Ann NY Acad Sci. 2005;1054:317-24.
38. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol. 2010;26(4):140-5.
39. Atichartakarn V, Angchaisuksiri P, Aryurachai K, Chuncharunee S, Thakkinstian A. In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy. Int J Hematol. 2003;77(3):299-303.
40. Atichartakarn V, Angchaisuksiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients. Br J Haematol. 2002;118(3):893-8.
41. Rachmilewitz EA, Peisach J, Bradley TB, Blumberg WE. Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature. 1969;222(5190):248-50.
42. Rachmilewitz EA, Peisach J, Blumberg WE. Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem. 1971;246(10):3356-66.
43. Peisach J, Blumberg WE, Ogawa S, Rachmilewitz EA, Oltzik R. The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem. 1971;246(10):3342-55.
44. Willardson BM, Thevenin BJ, Harrison ML, Kuster WM, Benson MD, Low PS. Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem. 1989;264(27):15893-9.
45. Low PS, Allen DP, Zioncheck TF, Chari P, Willardson BM, Geahlen RL, et al. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem. 1987; 262(10):4592-6.
46. Ferru E, Pantaleo A, Mannu F, Carta F, Turrini F. May band 3 hyper-phosphorylation have a functional role in microcyte formation in heterozygous thalassemias? Blood Cell Mol Dis. 2010;45(1):65-6.
47. Lutz HU, Bussolino F, Flepp R, Fasler S, Stammler P, Kazatchkine MD, et al. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA. 1987;84(21): 7368-72.
48. Asakura T, Minakata K, Adachi K, Russell MO, Schwartz E. Denatured hemoglobin in sickle erythrocytes. J Clin Invest. 1977;59(4): 633-40.
49. Barnhart MI, Lusher JM. Structural physiology of the human spleen. Am J Pediatr Hematol Oncol. 1979;1(4):311-30.